Site-Specific Cancer Incidence and Mortality after Cerebral Angiography with Radioactive Thorotrast

Authors:

Abstract
Travis, L. B., Hauptmann, M., Gaul, L. K., Storm, H. H., Goldman, M. B., Nyberg, U., Berger, E., Janower, M. L., Hall, P., Monson, R. R., Holm, L-E., Land, C. E., Schottenfeld, D., Boice, J. D., Jr. and Andersson, M. Site-Specific Cancer Incidence and Mortality after Cerebral Angiography with Radioactive Thorotrast. Radiat. Res. 160, 691–706 (2003). Few opportunities exist to evaluate the carcinogenic effects of long-term internal exposure to α-particle-emitting radionuclides. Patients injected with Thorotrast (thorium-232) during radiographic procedures, beginning in the 1930s, provide one such valuable opportunity. We evaluated site-specific cancer incidence and mortality among an international cohort of 3,042 patients injected during cerebral angiography with either Thorotrast (n = 1,650) or a nonradioactive agent (n = 1,392) and who survived 2 or more years. Standardized incidence ratios (SIR) for Thorotrast and comparison patients (Denmark and Sweden) were estimated and relative risks (RR), ...

This publication has 56 references indexed in Scilit: